Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
Completed · Phase 2
Conditions studied: Multiple Myeloma and Plasma Cell Neoplasm
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. GM-CSF may make cancer cells more sensitive to the effects of chemotherapy. Combining more than one drug with GM-CSF may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy, consisting of cyclophosphamide plus vincristine, following GM-CSF in treating patients with multiple myeloma that has not responded to previous treatment.
Key facts
- Study ID
- NCT00003490
- Run by
- The Cleveland Clinic
- People needed
- 30
- Starts
- 1998-10-01
- Expected to finish
- 2003-08-01
- Last updated by the study team
- 2013-12-04
Who can join
Age: 16 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cleveland Clinic Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.